Natural product-based therapy for Metastatic tumors: Sulindac, an anti-inflammatory drug, increases the expression of metastasis suppressor TIMP3 (TIMP metallopeptidase inhibitor 1) via down regulation of its target gene, 27/February/2015, 08.34 am

Natural product-based therapy for Metastatic tumors: Sulindac, an anti-inflammatory drug, increases the expression of metastasis suppressor TIMP3 (TIMP metallopeptidase inhibitor 1) via down regulation of its target gene, 27/February/2015, 08.34 am

Natural product-based therapy for Metastatic tumors: Sulindac, an anti-inflammatory drug, increases the expression of metastasis suppressor TIMP3 (TIMP metallopeptidase inhibitor 1) via down regulation of its target gene, 27/February/2015, 08.34 am 150 150

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Natural product-based therapy for Metastatic tumors: Sulindac, an anti-inflammatory drug, increases the expression of metastasis suppressor TIMP3 (TIMP metallopeptidase inhibitor 1) via down regulation of its target gene, 27/February/2015, 08.34 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that Sulindac, by suppressing the expression of its target geneit may increase the expression of TIMP3. Thereby, it may inhibit tumor progressionThus, pharmacological formulations encompassing “Sulindac or its analogues”  may be used to inhibit the progression of tumors.

Amount: $ 300

Undisclosed information: How Sulindac increases the expression of TIMP3

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org